Revance Therapeutics, Inc. (RVNC)
Feb 6, 2025 = RVNC was delisted (reason: acquired by Crown Laboratories)
3.650
0.00 (0.00%)
Inactive · Last trade price on Feb 6, 2025

Revance Therapeutics Analyst Ratings

Total Analysts
9
Consensus Rating
Hold
Price Target
$7.78
Upside
+113.15%

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aJan 17, 2025
Barclays
Barclays
Hold
Maintains
$7$3
HoldMaintains$7$3-17.81%Dec 23, 2024
Mizuho
Mizuho
Hold
Maintains
$6.66$3.1
HoldMaintains$6.66$3.1-15.07%Dec 10, 2024
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aNov 8, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$6.6
HoldReiterates$6.6+80.82%Nov 8, 2024
Needham
Needham
Hold
Reiterates
n/a
HoldReiteratesn/an/aOct 28, 2024
Barclays
Barclays
Hold
Downgrades
$10$7
HoldDowngrades$10$7+91.78%Sep 13, 2024
Needham
Needham
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 13, 2024
Guggenheim
Guggenheim
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 12, 2024
William Blair
William Blair
Hold
Downgrades
n/a
HoldDowngradesn/an/aAug 12, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$11$6
BuyMaintains$11$6+64.38%Aug 9, 2024
Stifel
Stifel
Strong Buy
Maintains
$24$20
Strong BuyMaintains$24$20+447.95%Aug 9, 2024
Needham
Needham
Strong Buy
Reiterates
$12
Strong BuyReiterates$12+228.77%Aug 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$12$11
Strong BuyMaintains$12$11+201.37%May 13, 2024
Goldman Sachs
Goldman Sachs
Hold
Maintains
$9$8
HoldMaintains$9$8+119.18%May 13, 2024
Piper Sandler
Piper Sandler
Buy
Reiterates
$20$11
BuyReiterates$20$11+201.37%May 10, 2024

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 10 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.